Literature DB >> 21580304

3-Chloro-6-{4-[3-(trifluoro-meth-yl)phen-yl]piperazin-1-yl}pyridazine.

Hakan Arslan, Semra Utku, Kenneth I Hardcastle, Mehtap Gökçe, Sheri Lense.   

Abstract

The title compound, C(15)H(14)ClF(3)N(4), was synthesized from 3,6-dichloro-pyridazine and 1-[3-(trifluoro-meth-yl)phen-yl]piper-azine. The piperazine ring is flanked by 3-chloro-pyridazine and 3-trifluoro-methyl-phenyl rings and adopts a chair conformation, whereas the 3-chloro-pyridazine and 3-trifluoro-methyl-phenyl rings are planar, with maximum deviations of 0.0069 (13) and 0.0133 (14) Å, respectively. The crystal structure is stabilized by weak inter-molecular C-H⋯N hydrogen-bond inter-actions.

Entities:  

Year:  2010        PMID: 21580304      PMCID: PMC2983628          DOI: 10.1107/S1600536810004137

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the synthesis and analgesic and anti-inflammatory activity of pyridazinone and pyridazine derivatives, see: Arslan et al. (2010 ▶); Giri & Mukhopadhyay (1998 ▶); Boissier et al. (1963 ▶); Gokce et al. (2001 ▶, 2004 ▶, 2005 ▶, 2009 ▶); Sahin et al. (2004 ▶); Dundar et al. (2007 ▶). For general background to pyrazolone derivatives, see: Amir et al. (2008 ▶); Banoglu et al. (2004 ▶). For puckering parameters, see: Cremer & Pople (1975 ▶).

Experimental

Crystal data

C15H14ClF3N4 M = 342.75 Monoclinic, a = 9.461 (6) Å b = 6.557 (4) Å c = 24.123 (16) Å β = 99.890 (9)° V = 1474.1 (16) Å3 Z = 4 Mo Kα radiation μ = 0.30 mm−1 T = 173 K 0.41 × 0.25 × 0.24 mm

Data collection

Bruker APEXII CCD diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2008 ▶) T min = 0.888, T max = 0.932 19935 measured reflections 3385 independent reflections 2781 reflections with I > 2σ(I) R int = 0.065

Refinement

R[F 2 > 2σ(F 2)] = 0.036 wR(F 2) = 0.101 S = 1.06 3385 reflections 208 parameters H-atom parameters constrained Δρmax = 0.32 e Å−3 Δρmin = −0.23 e Å−3 Data collection: APEX2 (Bruker, 2008 ▶); cell refinement: SAINT (Bruker, 2008 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL. Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536810004137/hg2643sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810004137/hg2643Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C15H14ClF3N4F(000) = 704
Mr = 342.75Dx = 1.544 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 7857 reflections
a = 9.461 (6) Åθ = 2.2–29.7°
b = 6.557 (4) ŵ = 0.30 mm1
c = 24.123 (16) ÅT = 173 K
β = 99.890 (9)°Block, colourless
V = 1474.1 (16) Å30.41 × 0.25 × 0.24 mm
Z = 4
Bruker APEXII CCD diffractometer3385 independent reflections
Radiation source: fine-focus sealed tube2781 reflections with I > 2σ(I)
graphiteRint = 0.065
φ and ω scansθmax = 27.5°, θmin = 1.7°
Absorption correction: multi-scan (SADABS; Bruker, 2008)h = −12→12
Tmin = 0.888, Tmax = 0.932k = −8→8
19935 measured reflectionsl = −31→31
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.036Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.101H-atom parameters constrained
S = 1.06w = 1/[σ2(Fo2) + (0.0589P)2 + 0.1216P] where P = (Fo2 + 2Fc2)/3
3385 reflections(Δ/σ)max = 0.005
208 parametersΔρmax = 0.32 e Å3
0 restraintsΔρmin = −0.23 e Å3
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
C11.35124 (16)0.4693 (2)0.76675 (6)0.0301 (3)
C21.23214 (15)0.35744 (19)0.78778 (5)0.0228 (3)
C31.15571 (14)0.45817 (19)0.82401 (5)0.0212 (3)
H31.18110.59390.83540.025*
C41.04104 (14)0.36134 (18)0.84400 (5)0.0194 (3)
C51.01095 (15)0.65546 (17)0.90409 (6)0.0235 (3)
H5A1.05630.73740.87750.028*
H5B1.08560.62190.93680.028*
C60.89367 (15)0.78043 (18)0.92372 (6)0.0241 (3)
H6A0.93640.90310.94390.029*
H6B0.82400.82620.89060.029*
C70.74380 (13)0.76537 (18)0.99646 (5)0.0186 (3)
C80.62135 (14)0.9883 (2)1.06758 (5)0.0220 (3)
C90.60062 (14)0.7770 (2)1.06879 (5)0.0236 (3)
H60.54580.71631.09390.028*
C100.66253 (14)0.66193 (19)1.03229 (5)0.0221 (3)
H100.65170.51791.03090.027*
C110.76124 (14)0.47012 (18)0.93414 (6)0.0223 (3)
H11A0.68460.50220.90190.027*
H11B0.71830.38810.96140.027*
C120.87797 (15)0.34660 (18)0.91356 (6)0.0226 (3)
H12A0.94760.29870.94640.027*
H12B0.83440.22500.89300.027*
C131.01216 (15)0.15733 (18)0.82706 (5)0.0238 (3)
H130.93650.08620.83990.029*
C141.09205 (16)0.05852 (19)0.79199 (5)0.0277 (3)
H141.0708−0.07960.78190.033*
C151.20215 (16)0.1564 (2)0.77128 (6)0.0268 (3)
H151.25520.08860.74670.032*
Cl10.54631 (4)1.14481 (6)1.113190 (14)0.03333 (13)
F11.47712 (10)0.45600 (17)0.80245 (4)0.0510 (3)
F21.37526 (11)0.39838 (16)0.71726 (4)0.0517 (3)
F31.32478 (10)0.66983 (13)0.75974 (4)0.0438 (3)
N10.95396 (11)0.46588 (15)0.87639 (4)0.0201 (2)
N20.81888 (12)0.66056 (15)0.96101 (4)0.0201 (2)
N30.75776 (12)0.96974 (15)0.99729 (4)0.0233 (3)
N40.69511 (12)1.08204 (16)1.03382 (5)0.0248 (3)
U11U22U33U12U13U23
C10.0290 (8)0.0347 (7)0.0294 (7)−0.0006 (6)0.0132 (6)−0.0075 (6)
C20.0230 (7)0.0259 (6)0.0203 (6)0.0020 (5)0.0054 (5)−0.0013 (5)
C30.0239 (7)0.0189 (6)0.0219 (6)−0.0001 (5)0.0065 (5)−0.0028 (5)
C40.0236 (7)0.0184 (6)0.0163 (6)0.0026 (5)0.0040 (5)0.0014 (4)
C50.0269 (7)0.0156 (6)0.0314 (7)−0.0049 (5)0.0147 (6)−0.0026 (5)
C60.0318 (8)0.0149 (5)0.0298 (7)−0.0027 (5)0.0175 (6)0.0001 (5)
C70.0176 (7)0.0194 (6)0.0189 (6)−0.0007 (5)0.0032 (5)0.0011 (4)
C80.0196 (7)0.0285 (6)0.0181 (6)0.0016 (5)0.0038 (5)−0.0036 (5)
C90.0201 (7)0.0307 (7)0.0211 (6)−0.0022 (5)0.0063 (5)0.0041 (5)
C100.0225 (7)0.0202 (6)0.0244 (6)−0.0025 (5)0.0063 (5)0.0031 (5)
C110.0231 (7)0.0182 (6)0.0274 (7)−0.0055 (5)0.0094 (5)−0.0023 (5)
C120.0281 (8)0.0144 (5)0.0278 (7)−0.0037 (5)0.0118 (6)−0.0007 (5)
C130.0314 (8)0.0186 (6)0.0226 (6)−0.0027 (5)0.0081 (6)0.0012 (5)
C140.0415 (9)0.0184 (6)0.0237 (6)0.0011 (6)0.0073 (6)−0.0026 (5)
C150.0324 (8)0.0258 (7)0.0237 (7)0.0055 (5)0.0089 (6)−0.0042 (5)
Cl10.0347 (2)0.0404 (2)0.0277 (2)0.00403 (15)0.01307 (16)−0.00988 (14)
F10.0271 (6)0.0704 (7)0.0556 (6)−0.0063 (5)0.0077 (5)0.0012 (5)
F20.0615 (7)0.0616 (6)0.0419 (6)−0.0158 (5)0.0369 (5)−0.0197 (5)
F30.0458 (6)0.0321 (5)0.0617 (6)−0.0037 (4)0.0324 (5)0.0035 (4)
N10.0250 (6)0.0148 (5)0.0228 (5)−0.0022 (4)0.0107 (5)−0.0010 (4)
N20.0239 (6)0.0144 (5)0.0246 (6)−0.0032 (4)0.0115 (5)0.0001 (4)
N30.0279 (7)0.0186 (5)0.0261 (6)−0.0026 (4)0.0121 (5)−0.0027 (4)
N40.0279 (7)0.0225 (5)0.0258 (6)−0.0017 (5)0.0096 (5)−0.0057 (4)
C1—F21.3364 (16)C8—N41.3129 (17)
C1—F31.3439 (18)C8—C91.400 (2)
C1—F11.3472 (18)C8—Cl11.7425 (14)
C1—C21.504 (2)C9—C101.3654 (18)
C2—C151.3920 (19)C9—H60.9500
C2—C31.3928 (18)C10—H100.9500
C3—C41.4114 (18)C11—N21.4681 (17)
C3—H30.9500C11—C121.5199 (18)
C4—N11.4073 (16)C11—H11A0.9900
C4—C131.4115 (18)C11—H11B0.9900
C5—N11.4691 (17)C12—N11.4676 (16)
C5—C61.5190 (18)C12—H12A0.9900
C5—H5A0.9900C12—H12B0.9900
C5—H5B0.9900C13—C141.3878 (19)
C6—N21.4650 (16)C13—H130.9500
C6—H6A0.9900C14—C151.388 (2)
C6—H6B0.9900C14—H140.9500
C7—N31.3462 (17)C15—H150.9500
C7—N21.3845 (16)N3—N41.3600 (15)
C7—C101.4236 (17)
F2—C1—F3106.53 (12)C10—C9—H6121.4
F2—C1—F1106.34 (12)C8—C9—H6121.4
F3—C1—F1105.59 (12)C9—C10—C7117.68 (12)
F2—C1—C2112.59 (12)C9—C10—H10121.2
F3—C1—C2112.66 (11)C7—C10—H10121.2
F1—C1—C2112.60 (13)N2—C11—C12111.21 (11)
C15—C2—C3121.75 (12)N2—C11—H11A109.4
C15—C2—C1119.53 (12)C12—C11—H11A109.4
C3—C2—C1118.72 (12)N2—C11—H11B109.4
C2—C3—C4120.89 (12)C12—C11—H11B109.4
C2—C3—H3119.6H11A—C11—H11B108.0
C4—C3—H3119.6N1—C12—C11112.04 (11)
N1—C4—C13121.30 (11)N1—C12—H12A109.2
N1—C4—C3121.89 (11)C11—C12—H12A109.2
C13—C4—C3116.70 (11)N1—C12—H12B109.2
N1—C5—C6111.56 (11)C11—C12—H12B109.2
N1—C5—H5A109.3H12A—C12—H12B107.9
C6—C5—H5A109.3C14—C13—C4121.34 (12)
N1—C5—H5B109.3C14—C13—H13119.3
C6—C5—H5B109.3C4—C13—H13119.3
H5A—C5—H5B108.0C15—C14—C13121.65 (12)
N2—C6—C5110.97 (11)C15—C14—H14119.2
N2—C6—H6A109.4C13—C14—H14119.2
C5—C6—H6A109.4C14—C15—C2117.62 (12)
N2—C6—H6B109.4C14—C15—H15121.2
C5—C6—H6B109.4C2—C15—H15121.2
H6A—C6—H6B108.0C4—N1—C12118.34 (10)
N3—C7—N2116.34 (10)C4—N1—C5117.42 (11)
N3—C7—C10121.81 (11)C12—N1—C5110.68 (10)
N2—C7—C10121.77 (12)C7—N2—C6117.79 (10)
N4—C8—C9124.58 (11)C7—N2—C11120.25 (11)
N4—C8—Cl1115.68 (10)C6—N2—C11111.53 (10)
C9—C8—Cl1119.73 (10)C7—N3—N4119.73 (10)
C10—C9—C8117.13 (12)C8—N4—N3119.05 (11)
D—H···AD—HH···AD···AD—H···A
C11—H11B···N4i0.992.693.628 (2)158
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
C11—H11B⋯N4i0.992.693.628 (2)158

Symmetry code: (i) .

  12 in total

1.  SYNTHESIS AND PHARMACOLOGICAL STUDY OF NEW PIPERAZINE DERIVATIVES. I. BENZYLPIPERAZINES.

Authors:  J R BOISSIER; R RATOUIS; C DUMONT
Journal:  J Med Chem       Date:  1963-09       Impact factor: 7.446

2.  Synthesis and antinociceptive activity of 6-substituted-3-pyridazinone derivatives.

Authors:  M Gokçe; D Dogruer; M F Sahin
Journal:  Farmaco       Date:  2001-03

3.  Synthesis of new Mannich bases of arylpyridazinones as analgesic and anti-inflammatory agents.

Authors:  Mehtap Gökçe; Gökçen Bakir; Mustafa Fethi Sahin; Esra Küpeli; Erdem Yeşilada
Journal:  Arzneimittelforschung       Date:  2005

4.  Synthesis and analgesic and anti-inflammatory activity of ethyl (6-substituted-3 (2H)-pyridazinone-2-yl)acetate derivatives.

Authors:  Yasemin Dündar; Mehtap Gökçe; Esra Küpeli; Mustafa Fethi Sahin
Journal:  Arzneimittelforschung       Date:  2007

5.  Synthesis and analgesic and anti-inflammatory activities 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(p-substituted/nonsubstituted benzal)hydrazone derivatives.

Authors:  Mehtap Gökçe; Semra Utku; Esra Küpeli
Journal:  Eur J Med Chem       Date:  2009-05-09       Impact factor: 6.514

6.  Synthesis and evaluation of the analgesic and anti-inflammatory activity of new 3(2H)-pyridazinone derivatives.

Authors:  Mehtap Gökçe; Mustafa Fethi Sahin; Esra Küpeli; Erdem Yeşilada
Journal:  Arzneimittelforschung       Date:  2004

7.  Amide derivatives of [6-(5-methyl-3-phenylpyrazole-1-yl)-3(2H)-pyridazinone-2-yl]acetic acids as potential analgesic and anti-inflammatory compounds.

Authors:  Erden Banoglu; Cağla Akoğlu; Serdar Unlü; Esra Küpeli; Erdem Yeşilada; M Fethi Sahin
Journal:  Arch Pharm (Weinheim)       Date:  2004-01       Impact factor: 3.751

8.  Synthesis and pharmacological evaluation of pyrazoline derivatives as new anti-inflammatory and analgesic agents.

Authors:  Mohammad Amir; Harish Kumar; Suroor A Khan
Journal:  Bioorg Med Chem Lett       Date:  2008-01-07       Impact factor: 2.823

9.  Synthesis and analgesic and antiinflammatory activity of methyl 6-substituted-3(2h)-pyridazinone-2-ylacetate derivatives.

Authors:  M F Sahina; B Badiçoglu; M Gökçe; E Küpeli; E Yeşilada
Journal:  Arch Pharm (Weinheim)       Date:  2004-08       Impact factor: 3.751

10.  3-Chloro-6-[4-(2-pyrid-yl)piperazin-1-yl]pyridazine.

Authors:  Hakan Arslan; Semra Utku; Kenneth I Hardcastle; Mehtap Gökçe; Sheri Lense
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.